Lixte Biotechnology Holdings, Inc. Common Stock (LIXT)
Lixte Biotechnology Holdings, Inc. is a biotechnology company focused on the discovery and development of targeted therapies for cancers and neurological disorders. The company utilizes its proprietary drug discovery platform to identify small-molecule compounds aimed at specific disease targets, with an emphasis on developing novel treatments with potential for clinical application.
Company News
LIXTE Biotechnology is advancing its cancer therapy pipeline with LB-100, a protein phosphatase 2A inhibitor targeting ovarian clear cell carcinoma, soft tissue sarcoma, and metastatic colon cancer, with potential trial results expected in late 2025.
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones index gaining over 300 points on Wednesday. The Dow traded up 0.78% to 39,589.55 while the NASDAQ fell 0.02% to 16,312.74. The S&P 500 also rose, gaining, 0.36% to 5,222.18. Check This Out: Top 3 Energy Stocks That May Keep You Up At Night In Q1 Â Leading and Laggin...
Here's some tips for sustainably investing in penny stocks The post How to Sustainably Invest in Penny Stocks appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.